フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Hutchmed (China) Limited 29 December 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Friday, December 29, 2023: HUTCHMED...
Hutchmed (China) Limited 29 December 2023 Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Friday, December 29, 2023:...
Hutchmed (China) Limited 21 December 2023 Overseas Regulatory Announcement - Continuing Connected Transactions HUTCHMED (China) Limited ("...
Hutchmed (China) Limited 07 December 2023 Overseas Regulatory Announcement - Disposal of Interest in Consumer Products Businesses HUTCHMED (China...
Hutchmed (China) Limited 30 November 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Thursday, November 30, 2023: HUTCHMED...
Hutchmed (China) Limited 09 November 2023 HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib) for Previously...
Hutchmed (China) Limited 24 October 2023 Vesting of awards under the Long Term Incentive Plan Hong Kong, Shanghai & Florham Park, NJ...
Hutchmed (China) Limited 29 September 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Friday, September 29, 2023: HUTCHMED...
Hutchmed (China) Limited 14 September 2023 Director's Share Dealing Hong Kong, Shanghai & Florham Park, NJ - Thursday, September 14...
Hutchmed (China) Limited 31 August 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Thursday, August 31, 2023: HUTCHMED...
Hutchmed (China) Limited 21 August 2023 HUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary...
Hutchmed (China) Limited 07 August 2023 Exercise of Share Options by a Director Hong Kong, Shanghai & Florham Park, NJ - Monday, August 7...
Hutchmed (China) Limited 31 July 2023 HUTCHMED Reports 2023 Interim Results and Provides Business Updates Strong execution on strategic direction...
Hutchmed (China) Limited 13 July 2023 HUTCHMED Announces Changes to Board of Directors and Technical Committee Ms Ling Yang to replace Mr Lefei...
Hutchmed (China) Limited 29 June 2023 Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Thursday, June 29, 2023:...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す